SEMA3B and rheumatoid arthritis: In RA MØIFN-γ, Sema3B alone promoted CD64 and CD206 expression and, in LPS-stimulated macrophages, reduced the expression of CD64, HLA-DR and, significatively, CD86 (Figure 2A).